Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 15 min ago
Peer-reviewedPublisher termsThe Journal of Immunology Author Choice

CRISPR-Cas9 screen identifies eIF4G2 as a regulator of CD8+ T cell dysfunction

  • Erin A Holcomb
  • Long Jiang
  • Ashley N Pearson
  • Jadyn James
  • Akshay Tate
  • Zhuwen Wang
  • Anwesha Dasgupta
  • Jim Clauwaert
  • Nicholas D Armas
  • Ameer L Elaimy
  • Dilrukshika S W Palagama
  • Samantha K Goodwin
9 more authors
  • Matthew J Kwiatkowski
  • Miguel Gijón
  • Meredith A Morgan
  • Adam H Courtney
  • Shannon A Carty
  • Amanda K Huber
  • Weiping Zou
  • John R Prensner
  • Michael D Green
Read full textDOICite

Related

  1. 321 Genome-scale CRISPR KO screen identifies PCBP2 as a tumor-intrinsic regulator of cancer cell sensitivity to human CD4+ T cell killing
    Paul Chapman, Iñaki Etxeberría, Benjamin Izar +19
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  2. Genome-wide CRISPR-screening identifies p53 as regulator of cancer cell sensitivity to the histone evicting anthracycline aclarubicin.
    Sabina Y van der Zanden, Koen Schipper, Merle A van Gelder +5
    Cell death & diseasePeer-reviewedCC BYFull textOncologyEurope PMCPMC
  3. In Vivo CRISPR Screen Identifies RPS19 as an Immunotherapy Target in Hepatocellular Carcinoma
    Lei He, Duo Yu, Fei Xie +18
    Advanced SciencePeer-reviewedCC BY 4.0Full textOncologyPMCEurope PMC
  4. Transcriptomic analysis identifies STAT1 as a potential key transcriptional regulator of T-cell dysfunction in AIHA
    Jing Xu, Linhui Hu, Haixiang Wan +4
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyGeneral medicineCrossrefDOAJEurope PMC
  5. An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model
    Mattia Fumagalli, Dongjie An, Luca Simula +15
    Molecular TherapyPeer-reviewedLicence not stated6 citedOncologyHAL

Cite

BibTeXRIS
BibTeX
@article{holcomb2026crisprcas9,
  title = {{CRISPR-Cas9 screen identifies eIF4G2 as a regulator of CD8+ T cell dysfunction}},
  author = {Erin A Holcomb and Long Jiang and Ashley N Pearson and Jadyn James and Akshay Tate and Zhuwen Wang and Anwesha Dasgupta and Jim Clauwaert and Nicholas D Armas and Ameer L Elaimy and Dilrukshika S W Palagama and Samantha K Goodwin and Matthew J Kwiatkowski and Miguel Gijón and Meredith A Morgan and Adam H Courtney and Shannon A Carty and Amanda K Huber and Weiping Zou and John R Prensner and Michael D Green},
  journal = {The Journal of Immunology Author Choice},
  year = {2026},
  month = oct,
  doi = {10.1093/jimmun/vkag187},
  url = {https://doi.org/10.1093/jimmun/vkag187},
}
RIS
TY  - JOUR
TI  - CRISPR-Cas9 screen identifies eIF4G2 as a regulator of CD8+ T cell dysfunction
AU  - Erin A Holcomb
AU  - Long Jiang
AU  - Ashley N Pearson
AU  - Jadyn James
AU  - Akshay Tate
AU  - Zhuwen Wang
AU  - Anwesha Dasgupta
AU  - Jim Clauwaert
AU  - Nicholas D Armas
AU  - Ameer L Elaimy
AU  - Dilrukshika S W Palagama
AU  - Samantha K Goodwin
AU  - Matthew J Kwiatkowski
AU  - Miguel Gijón
AU  - Meredith A Morgan
AU  - Adam H Courtney
AU  - Shannon A Carty
AU  - Amanda K Huber
AU  - Weiping Zou
AU  - John R Prensner
AU  - Michael D Green
PY  - 2026
DA  - 2026/10/13
JO  - The Journal of Immunology Author Choice
DO  - 10.1093/jimmun/vkag187
UR  - https://doi.org/10.1093/jimmun/vkag187
SN  - 0022-1767
SN  - 1550-6606
ER  -